Microbiome JPM 2026: Novo Nordisk’s Jacob Peterson on the Future of Obesity TherapeuticsBy adminJanuary 24, 20260 Novo Nordisk is doubling down on obesity and diabetes. Speaking with Inside Precision Medicine at the 2026 J.P. Morgan Healthcare…
